TrialAntimicrobial agents and chemotherapy2000

Population pharmacokinetics and pharmacodynamic modeling of abacavir (1592U89) from a dose-ranging, double-blind, randomized monotherapy trial with human immunodeficiency virus-infected subjects.

S Weller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.